What are the main impurities found in Escitalopram Oxalate?
Escitalopram oxalate, the active ingredient in certain antidepressants, can contain several impurities. Key impurities identified include desmethyl-escitalopram and the dichloro-escitalopram isomer [1]. Another significant impurity is the "keto-escitalopram" impurity [2].
Who manufactures impurity standards for Escitalopram Oxalate?
Companies specializing in the production of pharmaceutical reference standards often manufacture impurities related to escitalopram oxalate. These include specialized chemical synthesis companies that create and supply known impurities for analytical testing and quality control purposes.
How are these impurities controlled in pharmaceutical manufacturing?
Pharmaceutical manufacturers implement strict quality control measures to limit impurities in escitalopram oxalate. This involves rigorous testing of raw materials, in-process monitoring, and final product analysis to ensure that impurity levels remain within acceptable limits as defined by regulatory bodies like the FDA [3]. Analytical techniques such as High-Performance Liquid Chromatography (HPLC) are commonly employed for impurity profiling.
What is the significance of impurities in drug products?
Impurities in drug products can affect their safety and efficacy. Regulatory guidelines set strict limits for known and unknown impurities. Controlling these impurities is crucial to ensure that the drug performs as intended and does not pose any undue risk to patients [4].
Are there specific regulations regarding Escitalopram Oxalate impurities?
Regulatory agencies like the U.S. Food and Drug Administration (FDA) set guidelines for impurities in pharmaceutical products through pharmacopeial standards (e.g., USP) and other regulatory documents. These standards define acceptable limits for specific impurities and establish testing requirements for drug manufacturers [3][4].
How do patent expirations affect impurity manufacturing?
As patents for drugs like escitalopram oxalate expire, the market opens for generic manufacturers. This increased production of the active pharmaceutical ingredient (API) can lead to a greater demand for impurity reference standards from manufacturers. DrugPatentWatch.com provides information on patent expirations that can signal shifts in market dynamics [5].
Where can I find more information on pharmaceutical impurity standards?
Information on pharmaceutical impurity standards, including those for escitalopram oxalate, can be found through specialized chemical suppliers and pharmaceutical information resources. Websites like DrugPatentWatch.com offer insights into the intellectual property landscape of pharmaceuticals, which can be relevant to the manufacturing of both APIs and their related impurities [5].
---
Sources:
1. https://www.drugpatentwatch.com/blog/wp-content/uploads/2021/11/Drug-Impurities-1.png
2. https://www.drugpatentwatch.com/blog/drug-impurities-and-how-they-are-identified/
3. https://www.drugpatentwatch.com/blog/wp-content/uploads/2021/11/Drug-Impurities-2.png
4. https://www.drugpatentwatch.com/blog/wp-content/uploads/2021/11/Drug-Impurities-3.png
5. https://www.drugpatentwatch.com/